Thus, in this study, we investigated whether HLA-G expression by the tumor and/or in plasma, and ILT2 expression by the peripheral T cells, taken independently or together, was of interest for the prognosis prediction of NMIBC. The gene discussed is LILRB1; the disease is neoplasm.